These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35966763)

  • 1. Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction.
    Santra D; Maiti S
    Struct Chem; 2022; 33(5):1755-1769. PubMed ID: 35966763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and MD-simulation data suggest that Omicron spike epitopes are more interacting to IgG via better MHC recognition than Delta variant.
    Sarkar A; Santra D; Sundar Panja A; Maiti S
    Int Immunopharmacol; 2023 Oct; 123():110636. PubMed ID: 37499394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike.
    Banerjee A; Kanwar M; Santra D; Maiti S
    Transl Med Commun; 2022; 7(1):2. PubMed ID: 35136839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations.
    Solanki K; Rajpoot S; Kumar A; J Zhang KY; Ohishi T; Hirani N; Wadhonkar K; Patidar P; Pan Q; Baig MS
    Future Virol; 2022 Jul; ():. PubMed ID: 35935449
    [No Abstract]   [Full Text] [Related]  

  • 5. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2.
    Wang M; Yan H; Chen L; Wang Y; Li L; Zhang H; Miao L
    PLoS One; 2023; 18(5):e0285722. PubMed ID: 37200310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.
    Koley T; Goswami A; Kumar M; Upadhyay N; Hariprasad G
    Adv Appl Bioinform Chem; 2022; 15():21-27. PubMed ID: 35734581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex.
    Ching WY; Adhikari P; Jawad B; Podgornik R
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.
    Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD
    Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.
    Sabzian-Molaei F; Hosseini S; Alipour A; Ghaderi H; Fotouhi-Chahouki F; Hadi A; Shahsavarani H
    Phytomedicine; 2023 Mar; 111():154648. PubMed ID: 36681052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
    Rashid PMA; Salih GF
    Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor.
    Khan A; Khan SA; Zia K; Altowyan MS; Barakat A; Ul-Haq Z
    Front Chem; 2022; 10():892093. PubMed ID: 35755247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis.
    Ortega JT; Jastrzebska B; Rangel HR
    Pathogens; 2021 Dec; 11(1):. PubMed ID: 35055993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2.
    Philip AM; Ahmed WS; Biswas KH
    Comput Struct Biotechnol J; 2023; 21():1966-1977. PubMed ID: 36936816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies.
    Singh JK; Dubey S; Srivastava G; Siddiqi MI; Srivastava SK
    Comput Biol Med; 2023 Jan; 152():106392. PubMed ID: 36502697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations.
    Erol I; Kotil SE; Ortakci F; Durdagi S
    J Biomol Struct Dyn; 2023 Dec; 41(20):10774-10784. PubMed ID: 36591650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.